We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands.
All Keywords
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, SARS-CoV-2, coronavirus, SARS, Seroprevalence, Faroe Islands, 【초록키워드】 Prevalence, Sensitivity and specificity, Support, acute respiratory syndrome, island, conducted,
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, SARS-CoV-2, coronavirus, SARS, Seroprevalence, Faroe Islands, 【초록키워드】 Prevalence, Sensitivity and specificity, Support, acute respiratory syndrome, island, conducted,
우리는 2020년 11월에 페로 제도에서 두 번째 전국 중증 급성 호흡기 증후군 코로나바이러스 2 혈청 유병률 연구를 수행했습니다. 우리는 검사 민감도와 특이성을 조정한 후 조 혈청 유병률이 0.3%이고 유병률이 0.4%임을 발견했습니다. 이 낮은 혈청 유병률은 페로 제도에서 사용되는 예방 전략을 뒷받침합니다.